scispace - formally typeset
V

Valérie Seror

Researcher at French Institute of Health and Medical Research

Publications -  28
Citations -  738

Valérie Seror is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Population & Amniocentesis. The author has an hindex of 10, co-authored 28 publications receiving 517 citations. Previous affiliations of Valérie Seror include Aix-Marseille University & Institut de recherche pour le développement.

Papers
More filters
Journal ArticleDOI

A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation

Patrick Peretti-Watel, +11 more
- 01 Jul 2020 - 
Journal ArticleDOI

Time preferences, socioeconomic status and smokers' behaviour, attitudes and risk awareness.

Patrick Peretti-Watel, +5 more
- 23 Jan 2013 - 
TL;DR: In this paper, a cross-sectional telephone survey was conducted in France in 2008 on a representative national sample of people aged 18-75 (N = 2000, including 621 smokers).
Journal ArticleDOI

Social acceptability of HIV screening among pregnant women

Jean-Paul Moatti, +4 more
- 01 Jan 1990 - 
TL;DR: Social acceptability of testing for HIV prenatal testing in France appears to be based less on an in-depth knowledge about the risks of transmission from mother-to-fetus than on the general French context of free-of-charge mandatory prenatal care and on the potentially reassuring effect of a true negative test.
Journal ArticleDOI

Discounting health and money: New evidence using a more robust method

Arthur E. Attema, +5 more
- 09 May 2018 - 
TL;DR: Constant discounting fitted the data better than the hyperbolic discounting models that were considered, suggesting that at the aggregate level the direct method solves the puzzle of unrealistically high discount rates typically observed in applied economics.
Journal ArticleDOI

Care pathways for ectopic pregnancy: a population-based cost-effectiveness analysis.

Valérie Seror, +7 more
- 01 Apr 2007 - 
TL;DR: Conservative treatments are cost-effective with respect to salpingectomy, when subsequent fertility is at stake, and efforts should be made to increase the frequency of diagnostic ultrasound scans, making it possible to increase methotrexate use and cost-effectiveness.